71 related articles for article (PubMed ID: 38539263)
1. A systematic review and meta-analysis of long noncoding RNA 00963 expression and prognosis and clinicopathological characteristic in human cancers.
He J; Wang Z; Wang Y; Liu F; Fu L; Jiang X; Wang P; Chen H; Hu M; Cai H
Pathol Res Pract; 2023 Feb; 242():154291. PubMed ID: 36696806
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of the prognostic value and immunological role of IDO1 gene in pan-cancer.
Lin K; Wang Y; Liu F; You T; Liu X; Liu R; Li Z; Zhen C; Zhang Y; Liu X; Cai H
Eur J Med Res; 2024 Mar; 29(1):206. PubMed ID: 38539263
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value and immunological role of PD-L1 gene in pan-cancer.
Wang Y; Jiang H; Fu L; Guan L; Yang J; Ren J; Liu F; Li X; Ma X; Li Y; Cai H
BMC Cancer; 2024 Jan; 24(1):20. PubMed ID: 38166842
[TBL] [Abstract][Full Text] [Related]
4. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy.
Zhao X; Wang Y; Jiang X; Mo B; Wang C; Tang M; Rong Y; Zhang G; Hu M; Cai H
BMC Cancer; 2023 Feb; 23(1):194. PubMed ID: 36855091
[TBL] [Abstract][Full Text] [Related]
6. A pan-cancer analysis revealing the role of TIGIT in tumor microenvironment.
Wen J; Mao X; Cheng Q; Liu Z; Liu F
Sci Rep; 2021 Nov; 11(1):22502. PubMed ID: 34795387
[TBL] [Abstract][Full Text] [Related]
7. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
8. Dose-Dependent Effect of Tumor Mutation Burden on Cancer Prognosis Following Immune Checkpoint Blockade: Causal Implications.
Zheng M
Front Immunol; 2022; 13():853300. PubMed ID: 35720282
[No Abstract] [Full Text] [Related]
9. Artificial intelligence-based prediction for cancer-related outcomes in Africa: Status and potential refinements.
Adeoye J; Akinshipo A; Thomson P; Su YX
J Glob Health; 2022; 12():03017. PubMed ID: 35493779
[No Abstract] [Full Text] [Related]
10. Indoleamine 2,3-dioxygenase 1 regulates breast cancer tamoxifen resistance through interleukin-6/signal transducer and activator of transcription.
Zhao X; Jiang Y; Xu M; Hu J; Feng N; Deng H; Lu C; Huang T
Toxicol Appl Pharmacol; 2022 Apr; 440():115921. PubMed ID: 35157906
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the Expression and Prognostic Value of MSH2 in Pan-Cancer Based on Bioinformatics.
Qiu W; Ding K; Liao L; Ling Y; Luo X; Wang J
Biomed Res Int; 2021; 2021():9485273. PubMed ID: 34859104
[TBL] [Abstract][Full Text] [Related]
12. Discovery of the First Potent IDO1/IDO2 Dual Inhibitors: A Promising Strategy for Cancer Immunotherapy.
He X; He G; Chu Z; Wu H; Wang J; Ge Y; Shen H; Zhang S; Shan J; Peng K; Wei Z; Zou Y; Xu Y; Zhu Q
J Med Chem; 2021 Dec; 64(24):17950-17968. PubMed ID: 34854662
[TBL] [Abstract][Full Text] [Related]
13. Indoleamine 2,3-dioxygenase 1 is essential for sustaining durable antibody responses.
Lightman SM; Peresie JL; Carlson LM; Holling GA; Honikel MM; Chavel CA; Nemeth MJ; Olejniczak SH; Lee KP
Immunity; 2021 Dec; 54(12):2772-2783.e5. PubMed ID: 34788602
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and Prognostic Significance of Long Non-coding RNA MIAT in Human Cancers: A Review and Meta-Analysis.
Wang Y; Fu L; Lu T; Zhang G; Zhang J; Zhao Y; Jin H; Yang K; Cai H
Front Genet; 2021; 12():729768. PubMed ID: 34659354
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]